JAHMAAL WILLIS: Open Payments
NPI 1679273551 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 46 payments from 14 companies in 2025. Trend: 2023 $785 · 2024 $1,017 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $170 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| ABBVIE INC. | 4 | $74 |
| Baxter Healthcare | 3 | $69 |
| Lilly USA, LLC | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $43 |
| SHIELD THERAPEUTICS INC | 2 | $29 |
Products named: XIFAXAN, REXULTI, TRELEGY ELLIPTA, BREZTRI, Kerendia, Hillrom - Volara System, QULIPTA, MOUNJARO.
Industry payments across CA — which companies pay providers there.
